DJSG
EW icon

D.J. St. Germain’s Edwards Lifesciences EW Stock Holding History

D.J. St. Germain’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1K Hold
145
– – ﹤0.01% 651
2026
Q1 		$11.6K Hold
145
– – ﹤0.01% 647
2025
Q4 		$12.4K Buy
+145
New +$11.9K ﹤0.01% 638
2023
Q4 		– Sell
-45
Closed -$3.12K – 794
2023
Q3 		$3.12K Hold
45
– – ﹤0.01% 618
2023
Q2 		$4.25K Buy
+45
New +$3.91K ﹤0.01% 603
2022
Q4 		$3.36K Buy
+45
New +$3.47K ﹤0.01% 325

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

D.J. St. Germain's EW Position: Q2 2026 in Review

D.J. St. Germain held its Edwards Lifesciences (EW) position steady in Q2 2026 at 145 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #651.

D.J. St. Germain first reported a position in EW in Q4 2022 and has held it in 6 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • D.J. St. Germain held 145 shares of Edwards Lifesciences worth $13.1K as of Q2 2026.
  • D.J. St. Germain left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of D.J. St. Germain's portfolio in Q2 2026, its #651 holding.
  • D.J. St. Germain first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 6 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.